BURLINGTON,Laboratory Corporation’s revenues hit $752 million in the third quarter, an increase of nearly 15 percent over a year ago.
LapCorp (NYSE: LH) said earnings before restructuring and special charges were $85.1 million, a jump of 26 percent. Earnings climbed 28 percent to 59 cents per diluted share.
LabCorp also paid down $60 million in debt and repurchased $63 million stock.
Looking ahead, the company said it expected a boost from a new noninvasive screening test for colon cancer that was launched in August. LabCorp also plans to focus more on “higher-value genomic and esoteric tests.”